Wells Fargo initiated coverage of Henry Schein (HSIC) with an Equal Weight rating and $80 price target The stock’s risk/reward is balanced at ...
StockStory.org on MSN1h
3 Reasons HSIC is Risky and 1 Stock to Buy InsteadHenry Schein has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The ...
BofA analyst Allen Lutz double upgraded Henry Schein (HSIC) to Buy from Underperform with a price target of $84, up from $69. The firm believes ...
This was the stock's fourth consecutive day of losses.
This was the stock's second consecutive day of losses.
Henry Schein, Inc., has announced that Stanley M. Bergman, chairman of the board and CEO, has received the National Association of Wholesaler-Distributors (NAW) Dirk Van Dongen Lifetime ...
Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Henry Schein HSIC in the last three months. The table below offers a condensed view of their ...
The private-equity firm KKR has taken a big stake in the medical- and dental-supply company Henry Schein and plans to work with the company to improve its operations. KKR has amassed a large stake in ...
Henry Schein, Inc. (NASDAQ:HSIC) shares are trading higher on Wednesday. The medical and dental supplies distributor disclosed a strategic investment of an additional $250 million from funds ...
(Reuters) -Private equity firm KKR has taken a large stake in Henry Schein and reached a deal to add members to the company's board, the distributor of medical products said on Wednesday. Shares of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results